Compare iShares MSCI Australia ETF (EWA) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Australia ETF vs 22nd Century Group Inc — how do they compare? iShares MSCI Australia ETF trades at $28.62 (market cap $1.17B), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: iShares MSCI Australia ETF is far larger — about 1882× 22nd Century Group Inc's market cap, and iShares MSCI Australia ETF is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Australia ETF for 61 Days and 22nd Century Group Inc for 32 Days on average.
| EWA | XXII | |
|---|---|---|
Market Cap | $1.17B | $621.67K |
Volume | 2,121,231 | 45,625 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $30.43 | $483.00 |
52-Week Low | $24.95 | $0.80 |
Typical Hold Time | 61 Days | 32 Days |
Enterprise Value | — | -$3.69M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
The iShares MSCI Australia ETF (EWA) trades at $28.23, showing no change over the past 24 hours. Technical indicators are predominantly bearish, with moving averages signaling a sell and oscillators neutral. Recent news highlights institutional selling by Squarepoint Ops LLC and broader Australian market pressures from inflation concerns, though some analysts see upside potential tied to commodity exposure.
The outlook is mixed; EWA offers exposure to Australia's commodity-driven economy with potential for gains if raw material prices rise, but faces headwinds from inflation and monetary policy tightening. Key risks include economic sensitivity to global demand and market volatility. Analyst sentiment is divided, with some targeting over 20% upside.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares MSCI Australia ETF
EWA tracks the MSCI Australia Index, providing broad exposure to large and mid-cap companies in the Australian equity market. It is structurally dominated by the financial and materials sectors, serving as a key instrument for investors seeking a single-country view of Australia's resource-rich and stable economy.
Read more on EWA →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
